REQUEST A DEMO
Total
USD $0.00
Search more companies

Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Fnc Innofarmateh OOO Profile Updated: October 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) is a company in Russia, with a head office in Moscow. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was first established on October 24, 2012. In its most recent financial highlights, the company reported a net sales revenue increase of 49.05% in 2025. A growth of 14.97% was recorded in its total assets. The enterprise’s net profit margin decreased by 28.8% in 2025.

Headquarters
Mikluho-Maklaya, 34, 37P
Moscow; Moscow; Postal Code: 117279

Contact Details: Purchase the Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) report to view the information.
Financial Auditors:
Purchase the Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) report to view the information.
Incorporation Date:
October 24, 2012
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fnc Innofarmateh OOO (Фнц Иннофарматех ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
49.05%▲
Total Operating Revenue
49.05%▲
Operating Profit
-97.16%▼
Net Profit/Loss for the Period
-88.02%▼
Total Assets
14.97%▲
Total Equity
3.08%▲
Operating Profit Margin
-32.63%▼
Net Profit Margin
-28.8%▼
Return on Equity (ROE)
-22.75%▼
Quick Ratio
-24.78%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?